您的购物车当前为空
别名 Q134R
Q134R, a neuroprotective hydroxyquinoline derivative that suppresses nuclear factor of activated T cell (NFAT) signaling. Q134R can across blood-brain barrier. Q134R has the potential for Alzheimer’s disease (AD) and aging-related disorders research[1].


为众多的药物研发团队赋能,
让新药发现更简单!
Q134R, a neuroprotective hydroxyquinoline derivative that suppresses nuclear factor of activated T cell (NFAT) signaling. Q134R can across blood-brain barrier. Q134R has the potential for Alzheimer’s disease (AD) and aging-related disorders research[1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 1,570 | 5日内发货 | |
| 5 mg | ¥ 2,660 | 5日内发货 | |
| 25 mg | ¥ 9,160 | 5日内发货 | |
| 50 mg | ¥ 11,900 | 5日内发货 | |
| 100 mg | ¥ 17,500 | 5日内发货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,180 | 5日内发货 |
| 产品描述 | Q134R, a neuroprotective derivative of hydroxyquinoline, effectively inhibits nuclear factor of activated T-cell (NFAT) signaling and possesses the ability to cross the blood-brain barrier. This compound shows promise for research into Alzheimer’s disease (AD) and aging-related disorders[1]. |
| 体外活性 | Q134R (1-10 μM) suppresses NFAT signaling, without inhibiting calcineurin activity. Q134R partially inhibits NFAT activity in primary rat astrocytes, but does not prevent calcineurin-mediated dephosphorylation of a non-NFAT target, either in vivo, or in vitro[1]. |
| 体内活性 | Q134R (4 mg/kg; orally gavage; twice per day; for 7 days) treatment improves cognitive function in rodent models of AD‐like pathology[1]. |
| 别名 | Q134R |
| 分子量 | 410.39 |
| 分子式 | C22H17F3N4O |
| CAS No. | 2022949-46-6 |
| Smiles | Cc1ccnc(N[C@H](c2ccc(cc2)C(F)(F)F)c2ccc3cccnc3c2O)n1 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多